The literature describing 31P, 1H, 13C, 23Na and 19F MRS in vivo in human cancers is
reviewed. Cancers have typical metabolic characteristics in 31P and 1H MRS including high …

Magnetic resonance (MR) spectroscopy has received little attention from the clinical
radiology community. Indeed, most MR spectroscopic studies are performed by a small and …

BACKGROUND AND PURPOSE: Sensitivity, positive predictive value (PPV), and negative
predictive value (NPV) of conventional MR imaging in predicting glioma grade are not high …

BACKGROUND AND PURPOSE: Tumor progression is often difficult to distinguish from
nonneoplastic treatment response on the basis of MR images alone. This study correlates …

We introduce a fast and robust spatial‐spectral encoding method, which enables acquisition
of high resolution short echo time (13 ms) proton spectroscopic images from human brain …

Brain tumor metabolism was studied with hydrogen-1 magnetic resonance spectroscopy
and positron emission tomography with fluorine-18 fluorodeoxyglucose in 50 patients. N …

This study compared the effectiveness of relative cerebral blood volume, apparent diffusion
coefficient, and spectroscopic imaging in differentiating between primary high-grade gliomas …

The authors developed a hydrogen-1 proton magnetic resonance (MR) imaging method in
which metabolic information is acquired by obtaining multiple sections through the brain. A …

Purpose: Functional/metabolic information provided by MR-spectroscopy (MRSI) suggests
MRI may not be a reliable indicator of active and microscopic disease in malignant brain …

Magnetic resonance spectroscopy (MRS) is becoming more widely available for clinical
applications and is able to provide information about the metabolic properties of regions of …